Drug Profile
Research programme: anti-beta amyloid antibodies - Takeda
Alternative Names: anti-Aβ antibodies - Takeda; BA 27; BC 05Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Takeda
- Class
- Mechanism of Action Amyloid beta-protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Japan (Injection)
- 01 Nov 2006 Preclinical trials in Alzheimer's disease in Japan (Injection)